Seems they could have gotten this done fairly easily by now. They are a reporting company, they seem to have raised money to get things going. I wonder what the advantages are for the company to stay on the pinks. There must be some positive in their ability to raise cash from this position and they wish to remain here for the time being?
I see in this last K filing they had some revenues prior to becoming Intellicell Bioscience. Should be interesting what the Q will say.
One reason to remain as a Pink Sheet stock is less pressure to perform; maybe they are still raising capital. The Whiz guy quoted it may be a long hold...possibly...maybe. Time is a factor to some investors, not to others. As the company raises money and larger net worth investors get in, they need to perform or they'll end up trading less than $1.00 or lower. I was guessing the price of the stock would hover around $5.00 after the reverse-split, go down then go back up. At $5.00 or more, the company is no longer a "penny stock" as defined by the SEC. The next 10Q might provide some answers; I'm hoping it is positive.